Search research articles
Contact Us
Filters
Showing results (11-20 of 33) with videos related to
Page
of 4
Sort By:
The New England Journal of Medicine
|
October 22, 1970
Increased concentrations of serum nickel after acute myocardial infarction
F W Sunderman, S Nomoto, A M Pradhan, et al.
FEBS Letters
|
December 2, 1991
Inhibition of protein kinase C is associated with a decrease in c-myc expression in human myeloid leukemia cells
S H Bernstein, S M Kharbanda, M L Sherman, et al.
Biochemical Pharmacology
|
July 5, 1991
Effects of hexamethylene bisacetamide on induction of monocytic differentiation of human U-937 myeloid leukemia cells
S H Bernstein, M L Sherman, R Hass, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 1998
Sequential interleukin-3 and granulocyte-colony stimulating factor prior to and following high-dose etoposide and cyclophosphamide: a phase I/II trial
S H Bernstein, J P Fay, N P Christiansen, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
August 4, 2001
Human dendritic cells pulsed with autologous Epstein-Barr virus transformed B-cell lymphoblastoid cell (BCL) lysate elicit a BCL specific MHC-class II restricted T-cell response
M Sugano, T F Conway, R J Kelleher, et al.
Experimental Hematology
|
October 1, 1996
Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming of high-dose etoposide and cyclophosphamide: a pilot trial
S H Bernstein, N P Christiansen, J P Fay, et al.
Leukemia Research
|
October 1, 1994
Therapy with recombinant human erythropoietin in patients with myelodysplastic syndromes
R M Stone, S H Bernstein, G Demetri, et al.
Cancer Chemotherapy and Pharmacology
|
January 29, 1999
A phase I study of recombinant human soluble interleukin-1 receptor (rhu IL-1R) in patients with relapsed and refractory acute myeloid leukemia
S H Bernstein, J Fay, S Frankel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 19, 2013
A phase II multicenter trial of hyperCVAD MTX/Ara-C and rituximab in patients with previously untreated mantle cell lymphoma; SWOG 0213
S H Bernstein, E Epner, J M Unger, et al.
Journal of Leukocyte Biology
|
June 1, 1995
Profile of immunoglobulin heavy chain variable gene repertoires and highly selective detection of malignant clonotypes in acute lymphoblastic leukemia
S J Greenberg, Y Choi, M Ballow, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 33) with videos related to
Sort By:
Page
of 4
The New England Journal of Medicine
|
October 22, 1970
Increased concentrations of serum nickel after acute myocardial infarction
F W Sunderman, S Nomoto, A M Pradhan, et al.
FEBS Letters
|
December 2, 1991
Inhibition of protein kinase C is associated with a decrease in c-myc expression in human myeloid leukemia cells
S H Bernstein, S M Kharbanda, M L Sherman, et al.
Biochemical Pharmacology
|
July 5, 1991
Effects of hexamethylene bisacetamide on induction of monocytic differentiation of human U-937 myeloid leukemia cells
S H Bernstein, M L Sherman, R Hass, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 1998
Sequential interleukin-3 and granulocyte-colony stimulating factor prior to and following high-dose etoposide and cyclophosphamide: a phase I/II trial
S H Bernstein, J P Fay, N P Christiansen, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
August 4, 2001
Human dendritic cells pulsed with autologous Epstein-Barr virus transformed B-cell lymphoblastoid cell (BCL) lysate elicit a BCL specific MHC-class II restricted T-cell response
M Sugano, T F Conway, R J Kelleher, et al.
Experimental Hematology
|
October 1, 1996
Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming of high-dose etoposide and cyclophosphamide: a pilot trial
S H Bernstein, N P Christiansen, J P Fay, et al.
Leukemia Research
|
October 1, 1994
Therapy with recombinant human erythropoietin in patients with myelodysplastic syndromes
R M Stone, S H Bernstein, G Demetri, et al.
Cancer Chemotherapy and Pharmacology
|
January 29, 1999
A phase I study of recombinant human soluble interleukin-1 receptor (rhu IL-1R) in patients with relapsed and refractory acute myeloid leukemia
S H Bernstein, J Fay, S Frankel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 19, 2013
A phase II multicenter trial of hyperCVAD MTX/Ara-C and rituximab in patients with previously untreated mantle cell lymphoma; SWOG 0213
S H Bernstein, E Epner, J M Unger, et al.
Journal of Leukocyte Biology
|
June 1, 1995
Profile of immunoglobulin heavy chain variable gene repertoires and highly selective detection of malignant clonotypes in acute lymphoblastic leukemia
S J Greenberg, Y Choi, M Ballow, et al.
Page
of 4